Literature DB >> 16767315

Human immunodeficiency virus and the central nervous system.

Sergio Monteiro de Almeida1, Scott Letendre, Ron Ellis.   

Abstract

The pandemic of HIV/AIDS continues to grow daily. Incident cases among women, intravenous drug users and ethnic minorities comprise the fastest growing segment of the HIV-infected population, and the number of HIV-infected individuals over the age of 50 is growing rapidly. Today, the central nervous system and the immune system are seen as main targets of HIV infection. Significant progress in the knowledge and treatment of AIDS has been obtained in recent years. The neurological manifestations directly related to HIV are acute viral meningitis, chronic meningitis, HIV-associated dementia (HAD), vacuolar myelopathy, and involvement of the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767315     DOI: 10.1590/s1413-86702006000100009

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  10 in total

Review 1.  Towards nanomedicines for neuroAIDS.

Authors:  Vidya Sagar; Sudheesh Pilakka-Kanthikeel; Ravi Pottathil; Shailendra K Saxena; Madhavan Nair
Journal:  Rev Med Virol       Date:  2014-01-07       Impact factor: 6.989

Review 2.  Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.

Authors:  Anupam Sarma; Malay K Das
Journal:  Mol Biomed       Date:  2020-12-10

Review 3.  Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.

Authors:  Madhavan Nair; Rahul Dev Jayant; Ajeet Kaushik; Vidya Sagar
Journal:  Adv Drug Deliv Rev       Date:  2016-03-02       Impact factor: 15.470

4.  Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.

Authors:  Vidya Sagar; S Pilakka-Kanthikeel; Paola C Martinez; V S R Atluri; M Nair
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

5.  Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.

Authors:  Bhavin K Patel; Rajesh H Parikh; Nilesh Patel
Journal:  Int J Nanomedicine       Date:  2018-03-15

Review 6.  Highlighting the Role of Cognitive and Brain Reserve in the Substance use Disorder Field.

Authors:  D Cutuli; D Ladrón de Guevara-Miranda; E Castilla-Ortega; L J Santín; P Sampedro-Piquero
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

7.  Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells.

Authors:  Sanne Simone Kaalund; Annette Johansen; Katrine Fabricius; Bente Pakkenberg
Journal:  Front Neurosci       Date:  2020-01-15       Impact factor: 4.677

Review 8.  Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.

Authors:  Anupam Sarma; Malay K Das
Journal:  Mol Biomed       Date:  2020-12-10

9.  The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.

Authors:  Lachlan R Gray; Gilda Tachedjian; Anne M Ellett; Michael J Roche; Wan-Jung Cheng; Gilles J Guillemin; Bruce J Brew; Stuart G Turville; Steve L Wesselingh; Paul R Gorry; Melissa J Churchill
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Astrocyte Senescence and Metabolic Changes in Response to HIV Antiretroviral Therapy Drugs.

Authors:  Justin Cohen; Luca D'Agostino; Joel Wilson; Ferit Tuzer; Claudio Torres
Journal:  Front Aging Neurosci       Date:  2017-08-29       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.